Declining genital warts in young women in England associated with HPV 16/18 vaccination: An ecological study

Journal of Infectious Diseases

Volumn 208, Issue 9, 2013, Pages 1397-1403

  Howell Jones, Rebecca ^a   Soldan, Kate ^a   Wetten, Sally ^a   Mesher, David ^a   Williams, Tim ^b   Gill, O Noel ^a   Hughes, Gwenda ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

Cervarix; genital warts; HPV immunization; surveillance

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GONORRHEA; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; UNITED KINGDOM; VACCINATION; CONDYLOMATA ACUMINATA; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOLOGY; INCIDENCE; MALE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; CONDYLOMATA ACUMINATA; ENGLAND; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRUS VACCINES; VACCINATION; YOUNG ADULT;

EID: 84885393034     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit361     Document Type: Article

References (25)

1. Health Protection Agency. Trends in genital warts and genital herpes diagnoses in the United Kingdom. Health Protection Report, 2007; 1
2. Health Protection Agency. Trends in genital herpes and genital warts infections, United Kingdom: 1999 to 2008. Health Protection Report, 2009; 3
3. Nicoll A, Hughes G, Donnelly M, et al. Assessing the impact of national anti-HIV sexual health campaigns: Trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect 2001; 77:242-7
4. Health Protection Agency. Sexually transmitted infections in England, 2011. Health Protection Report, 2012; 6
5. Department of Health. Annual HPV vaccine uptake in England: 2010/ 11. http://media.dh.gov.uk/network/211/files/2012/03/120319-HPV- UptakeReport2010-11-revised-acc.pdf. Accessed April 2013
6. Lu B, Kumar A, Castellsague X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: A systematic review & meta-Analysis. BMC Infect Dis 2011; 11
7. Lacey CJN, Lowndes CM, Shah KV. Burden and management of noncancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24:35-41
8. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87:544-7
9. Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008; 337:a769
10. Lehtinen M, Palmroth J, Merikukka M, Kaasila M, Apter D, Paavonen J. Competition of vaccine and non-vaccine HPV types before and after mass-vaccination, Eurogin 2011, Lisbon [SS 2-1].
11. Hepburn HM, Seipel M, Schwarz T, Pawlita M, Waterboer T, Kaufmann AM. Ex vivo monitoring of cellular memory responses in young women immunized with either Gardasil or Cervarix four years prior to enrollment, IPV 2009, Malmo [P-13.13].
12. Szarewski A, Skinner SR, Garland S, et al. Efficacy of the HPV-16/18 AS04-Adjuvanted vaccine against low risk HPV types (PATRICIA randomised trial): An unexpected observation. 2013; 208:1391-6
13. Department of Health. Annual HPV vaccine coverage in England in 2009/2010. http://www.dh.gov.uk/en/Publicationsandstatistics/Publi cations/PublicationsPolicyAndGuidance/DH-123795. Accessed August 2011
14. Savage EJ, Marsh K, Duffell S, Ison CA, Zaman A, Hughes G. Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill 2012; 17
15. Health Protection Agency. Genitourinary Medicine Clinic Activity Dataset (GUMCAD). http://www.hpa.org.uk/web/HPAweb&HPAweb Standard/HPAweb-C/ 1201265888302. Accessed August 2011
16. Annual Mid-year Population Estimates for England and Wales. Available at: Http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-forengland-And- wales/mid-2002-To-mid-2010-revised-national-/stb -mid-2002-To-mid-2010-revised- population-estimates-for-england-And-wales. html. Accessed August 2013
17. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012; 3:89-99
18. Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K. Genital warts and cost of care in England. Sex Transm Infect 2011; 87: 464-8
19. Yung M, Denholm R, Peake J, Hughes G. Distribution and characteristics of sexual health service provision in primary and community care in England. Int J STD AIDS 2010; 21:650-2
20. Hughes A, Mesher D, White J, Soldan K. Coverage of the English National HPV Immunisation Programme (2008-2011) among 12-17 year old females by area-level deprivation score. Submitted for publication 2012
21. Health Protection Agency. Further increase in chlamydia screening coverage in 2010/11. Health Protection Report, 2011; 5:21-3
22. Hughes G, Catchpole M, Rogers PA, et al. Comparison of risk factors for four sexually transmitted infections: Results from a study of attenders at three genitourinary medicine clinics in England. Sex Transm Infect 2000; 76:262-7
23. Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: Cross-sectional and longitudinal surveys conducted in England. Vaccine 2012; 30:4939-44
24. Sturegard E, Johnsson A, Gustafsson E, Dillner J. Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project. Lakartidningen 2008; 105:3648-50
25. Ball SLR, Winder DM, Vaughan K, et al. Analysis of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 2011; 83:1345-50